CA3265497A1 - Procédés d'évaluation de l'état d'utilisation de tabac - Google Patents

Procédés d'évaluation de l'état d'utilisation de tabac

Info

Publication number
CA3265497A1
CA3265497A1 CA3265497A CA3265497A CA3265497A1 CA 3265497 A1 CA3265497 A1 CA 3265497A1 CA 3265497 A CA3265497 A CA 3265497A CA 3265497 A CA3265497 A CA 3265497A CA 3265497 A1 CA3265497 A1 CA 3265497A1
Authority
CA
Canada
Prior art keywords
methods
use status
tobacco use
assessing
assessing tobacco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3265497A
Other languages
English (en)
Inventor
Hannah BIEGEL
Yolanda Hagar
Kelsey M. LOUPY
Clare Paterson
Rachel M. Ostroff
Laura Mae Sampson
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Publication of CA3265497A1 publication Critical patent/CA3265497A1/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3265497A 2022-09-23 2023-09-22 Procédés d'évaluation de l'état d'utilisation de tabac Pending CA3265497A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263409338P 2022-09-23 2022-09-23
US63/409,338 2022-09-23
PCT/US2023/033449 WO2024064322A2 (fr) 2022-09-23 2023-09-22 Procédés d'évaluation de l'état d'utilisation de tabac

Publications (1)

Publication Number Publication Date
CA3265497A1 true CA3265497A1 (fr) 2024-03-28

Family

ID=88417207

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3265497A Pending CA3265497A1 (fr) 2022-09-23 2023-09-22 Procédés d'évaluation de l'état d'utilisation de tabac

Country Status (4)

Country Link
EP (1) EP4591066A2 (fr)
JP (1) JP2025534223A (fr)
CA (1) CA3265497A1 (fr)
WO (1) WO2024064322A2 (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US6001577A (en) 1998-06-08 1999-12-14 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
EP1493825A3 (fr) 1990-06-11 2005-02-09 Gilead Sciences, Inc. Procédé pour la production de ligands constitués par des acides nucléiques
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US6458539B1 (en) 1993-09-17 2002-10-01 Somalogic, Inc. Photoselection of nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
MX2010000578A (es) 2007-07-17 2010-04-30 Somalogic Inc Metodo para generar aptameros con constantes de disociacion mejoradas.
MX2012014268A (es) 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
CA2809282C (fr) 2010-09-27 2017-09-12 Somalogic, Inc. Biomarqueurs de mesotheliome et utilisations de ceux-ci

Also Published As

Publication number Publication date
WO2024064322A2 (fr) 2024-03-28
EP4591066A2 (fr) 2025-07-30
JP2025534223A (ja) 2025-10-15
WO2024064322A3 (fr) 2024-05-02

Similar Documents

Publication Publication Date Title
EP4096694A4 (fr) Biomarqueurs pulmonaires et leurs méthodes d'utilisation
EP3969439A4 (fr) Inhibiteurs d'acss2 et leurs procédés d'utilisation
EP3986894A4 (fr) Inhibiteurs d'ectonucléotidases et leurs procédés d'utilisation
EP4028013A4 (fr) Inhibiteurs de sarm1
EP4146236A4 (fr) Composés théranostiques contenant du cuivre et leurs méthodes d'utilisation
EP3781712A4 (fr) Procédé de normalisation et de quantification de donnees de séquençage
EP4084686A4 (fr) Usage des valeurs de co dans le sevrage tabagique
HK40127562A (zh) 评估烟草使用状况的方法
CA3265497A1 (fr) Procédés d'évaluation de l'état d'utilisation de tabac
CA3248844A1 (fr) Composés anti-b7-h3 et méthodes d'utilisation
EP4010010A4 (fr) Procédés d'amélioration du fonctionnement d'un organe
IL317645A (en) Methods for preparing tolbrutinib
EP4081233A4 (fr) Composition et procédés de fabrication
AU2023903814A0 (en) Method of assessing lung health
AU2022903563A0 (en) Method of Assessing Lung Health
HK40106921A (zh) Mazdutide的应用
HK40091795A (en) Use of 5-nitro-8-hydroxyquinoline
CA3286365A1 (fr) Méthodes d'évaluation de la fonction plaquettaire
AU2024239181A1 (en) Methods for assessing platelet function
EP4319743A4 (fr) Co-cristaux d'upadacitinib
CA3284174A1 (fr) Compositions de biomarqueurs et procédés associés d'utilisation
AU2019904598A0 (en) Smoking Instrument
AU2022901867A0 (en) Smoking Implement
AU2023902862A0 (en) Methods and kits for assessing medical risk
AU2022902748A0 (en) Methods and kits for assessing medical risk

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20250220

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250220

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED

Effective date: 20250220

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20250523

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250523

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250523

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250523

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250523

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250915

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250915